These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 13851575)
1. Clinical toxicity studies of a monoamine oxidase inhibitor. GREENBLATT IJ; KAHN A Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575 [No Abstract] [Full Text] [Related]
2. An unusual reaction to an MAO inhibitor. TUPIN J Dis Nerv Syst; 1961 Nov; 22():641-4. PubMed ID: 13923104 [No Abstract] [Full Text] [Related]
3. Stupor from dextroamphetamineamobarbital and monoamine oxidase inhibitor, phenelzine. ROECKER RD; LANE M J Med Soc N J; 1961 Feb; 58():47-9. PubMed ID: 13742660 [No Abstract] [Full Text] [Related]
4. Studies on monoamine oxidase. 2: p-Methylphenyl hydrazine, a potent and selective monoamine oxidase inhibitor. ARAI A Jpn J Pharmacol; 1960 Mar; 9():159-68. PubMed ID: 13683948 [No Abstract] [Full Text] [Related]
5. Monoamine oxidase inhibitors. II. Some amino and dialkylaminobenzyl hydrazines and their acyl derivatives. GARDNER TS; WENIS E; LEE J J Med Pharm Chem; 1961 Mar; 3():241-52. PubMed ID: 13896916 [No Abstract] [Full Text] [Related]
6. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives. PLETSCHER A Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482 [No Abstract] [Full Text] [Related]
7. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines. GARDNER TS; WENIS E; LEE J J Med Pharm Chem; 1960 Apr; 2():133-45. PubMed ID: 13826540 [No Abstract] [Full Text] [Related]
8. The pharmacological evaluation of monoamine oxidase inhibitors. LESSIN AW Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030 [No Abstract] [Full Text] [Related]
9. A non-hydrazine monoamine oxidase inhibitor with antihypertensive properties. HORWITZ D; SJOERDSMA A Proc Soc Exp Biol Med; 1961 Jan; 106():118-20. PubMed ID: 13716049 [No Abstract] [Full Text] [Related]
10. Anticonvulsant properties of monoamine oxidase inhibitors. PROCKOP DJ; SHORE PA; BRODIE BB Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994 [No Abstract] [Full Text] [Related]
11. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine. MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138 [TBL] [Abstract][Full Text] [Related]
13. [Study of the action of the isopropylhydrazide of p-chlorophenoxyacetic acid (P.C. 603), a new monoamine oxidase inhibitor, in depressive states]. BORENSTEIN P; DABBAH M; KRAMARZ P; HENON C Ann Med Psychol (Paris); 1961 Oct; 119(2)():554-65. PubMed ID: 13871268 [No Abstract] [Full Text] [Related]
14. Monoamine oxidase inhibitors in the treatment of angina pectoris. RUSSEK HI Angiology; 1960 Feb; 11():76-80. PubMed ID: 14440277 [No Abstract] [Full Text] [Related]
16. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor. CANAL N; MAFFEI-FACCIOLI A J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360 [No Abstract] [Full Text] [Related]
17. A report on the effects of phenelzine (nardil), a monoamine oxidase inhibitor, in depressed patients. MIDDLEFELL R; FROST I; EGAN GP; EATON H J Ment Sci; 1960 Oct; 106():1533-8. PubMed ID: 13770370 [No Abstract] [Full Text] [Related]
18. The importance of the monoamine oxidase inhibitors in cardiovascular disease. GRIFFITH GC Am J Cardiol; 1960 Dec; 6():1103-5. PubMed ID: 13708592 [No Abstract] [Full Text] [Related]
19. On the mechanism of action of monoamine oxidase inhibitors in angina pectoris. PLETSCHER A; GEY KF J Am Geriatr Soc; 1961 Jun; 9():410-8. PubMed ID: 13736338 [No Abstract] [Full Text] [Related]
20. Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors. OBLATH RW; GRIFFITH GC J Am Geriatr Soc; 1961 Jun; 9():427-31. PubMed ID: 13730182 [No Abstract] [Full Text] [Related] [Next] [New Search]